| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 2035-2037, Copyright © 1990 by Endocrine Society
ARTICLES |
T Unterman, R Lascon, MB Gotway, D Oehler, A Gounis, RA Simmons and ES Ogata
Department of Medicine, University of Illinois College of Medicine, Chicago.
Insulin-like growth factors (IGFs) circulate in association with a family of specific binding proteins (BPs). Recently, we reported that circulating levels of IGFBP-1 and IGFBP-2 are increased in streptozotocin-diabetic adult rats and are differentially regulated in accordance with insulin and metabolic status. Since IGF BPs appear to be important modulators of IGF bioactivity in post-natal life, we asked whether serum levels of IGF BPs also might be altered in utero when the delivery of maternal nutrients is restricted and fetal growth is impaired. Bilateral uterine artery ligation or sham surgery was performed on maternal rats on d 19 of gestation (term 21.5 d). One day after ligation (d 20), fetuses were (SGA) compared to shams (3.1 +/- 1 vs 3.7 +/- 0.2 g, p less than .02) and serum levels of glucose (70 +/- 5 vs 96 +/- 6 mg/dL, p less than .01) and insulin (62 +/- 4 vs 138 +/- 14 microU/mL) also were reduced. In contrast, serum [125I]IGF-I binding activity was markedly increased in SGA litters compared to sham (65 +/- 5% maximum binding with 2.5 microL/mL SGA serum vs 14 +/- 3% for sham serum, p less than .001), and correlated with fetal weight (r = -0.539, p less than .05) and insulin (r = -0.622, p less than .05). Ligand blotting with [125I]IGF-I revealed that serum levels of IGFBP-1 (32 K) were greater in SGA than shams, while immunoblotting with specific antiserum demonstrated that levels of IGFBP-2 (34 K), the major fetal rat IGF BP, were similar in serum from SGA and shams litters. Affinity labeling and immunoprecipitation confirmed that IGF binding activity is increased in SGA, due largely to increased availability of IGFBP-1. In addition, Northern analysis of hepatic RNA revealed that the abundance of IGFBP-1 mRNA is increased in the SGA fetal rat, while hepatic mRNA for IGFBP-2 is similar in SGA and sham-operated litters. We conclude that circulating levels of IGFBP-1 and the abundance of hepatic mRNA are increased in the SGA fetal rat. IGFBP-1 may be an important modulator of IGF bioactivity and somatic growth in utero.
This article has been cited by other articles:
![]() |
O. Kevorkova, M. Ethier-Chiasson, and J. Lafond Differential Expression of Glucose Transporters in Rabbit Placenta: Effect of Hypercholesterolemia in Dams Biol Reprod, March 1, 2007; 76(3): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben Lagha, D. Seurin, Y. Le Bouc, M. Binoux, A. Berdal, P. Menuelle, and S. Babajko Insulin-Like Growth Factor Binding Protein (IGFBP-1) Involvement in Intrauterine Growth Retardation: Study on IGFBP-1 Overexpressing Transgenic Mice Endocrinology, October 1, 2006; 147(10): 4730 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ke, Q. Lei, S. J. James, S. L. Kelleher, S. Melnyk, S. Jernigan, X. Yu, L. Wang, C. W. Callaway, G. Gill, et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats Physiol Genomics, March 13, 2006; 25(1): 16 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kajimura, K. Aida, and C. Duan Understanding Hypoxia-Induced Gene Expression in Early Development: In Vitro and In Vivo Analysis of Hypoxia-Inducible Factor 1-Regulated Zebra Fish Insulin-Like Growth Factor Binding Protein 1 Gene Expression Mol. Cell. Biol., February 1, 2006; 26(3): 1142 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Simmons, I. Suponitsky-Kroyter, and M. A. Selak Progressive Accumulation of Mitochondrial DNA Mutations and Decline in Mitochondrial Function Lead to {beta}-Cell Failure J. Biol. Chem., August 5, 2005; 280(31): 28785 - 28791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Shaikh, F H Bloomfield, M K Bauer, H H Phua, R S Gilmour, and J E Harding Amniotic IGF-I supplementation of growth-restricted fetal sheep alters IGF-I and IGF receptor type 1 mRNA and protein levels in placental and fetal tissues J. Endocrinol., July 1, 2005; 186(1): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kajimura, K. Aida, and C. Duan From the Cover: Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation PNAS, January 25, 2005; 102(4): 1240 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vuguin, E. Raab, B. Liu, N. Barzilai, and R. Simmons Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation Diabetes, October 1, 2004; 53(10): 2617 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Peterside, M. A. Selak, and R. A. Simmons Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1258 - E1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. El Khattabi, F. Gregoire, C. Remacle, and B. Reusens Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E991 - E1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Selak, B. T. Storey, I. Peterside, and R. A. Simmons Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E130 - E137. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boloker, S. J. Gertz, and R. A. Simmons Gestational Diabetes Leads to the Development of Diabetes in Adulthood in the Rat Diabetes, May 1, 2002; 51(5): 1499 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bajoria, S. R. Sooranna, S. Ward, and M. Hancock Placenta as a Link between Amino Acids, Insulin-IGF Axis, and Low Birth Weight: Evidence from Twin Studies J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 308 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Simmons, L. J. Templeton, and S. J. Gertz Intrauterine Growth Retardation Leads to the Development of Type 2 Diabetes in the Rat Diabetes, October 1, 2001; 50(10): 2279 - 2286. [Abstract] [Full Text] |
||||
![]() |
M. H. Vickers, B. A. Ikenasio, and B. H. Breier IGF-I Treatment Reduces Hyperphagia, Obesity, and Hypertension in Metabolic Disorders Induced by Fetal Programming Endocrinology, September 1, 2001; 142(9): 3964 - 3973. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bajoria, M. J. Gibson, S. Ward, S. R. Sooranna, J. P. Neilson, and M. Westwood Placental Regulation of Insulin-Like Growth Factor Axis in Monochorionic Twins with Chronic Twin-Twin Transfusion Syndrome J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3150 - 3156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Popovici, M. Lu, S. Bhatia, G. H. Faessen, A. J. Giaccia, and L. C. Giudice Hypoxia Regulates Insulin-Like Growth Factor-Binding Protein 1 in Human Fetal Hepatocytes in Primary Culture: Suggestive Molecular Mechanisms for in Utero Fetal Growth Restriction Caused by Uteroplacental Insufficiency J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2653 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Tazuke, N. M. Mazure, J. Sugawara, G. Carland, G. H. Faessen, L.-F. Suen, J. C. Irwin, D. R. Powell, A. J. Giaccia, and L. C. Giudice Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia PNAS, August 18, 1998; 95(17): 10188 - 10193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gay, D. Seurin, S. Babajko, S. Doublier, M. Cazillis, and M. Binoux Liver-Specific Expression of Human Insulin-Like Growth Factor Binding Protein-1 in Transgenic Mice: Repercussions on Reproduction, Ante- and Perinatal Mortality and Postnatal Growth Endocrinology, July 1, 1997; 138(7): 2937 - 2947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |